Science
Dharka aan la arki karin, bayoolajiga synthetic, kiimiko madadaalo leh, iyo kobcinta fikirka sayniska-boggani wuxuu daboolayaa isbeddellada iyo wararka hagi doona mustaqbalka sayniska.
256465
signalka
https://www.nature.com/articles/s41598-024-59884-w?code=dcc221e3-6d58-4623-8de1-f3e402b3b9d2&error=cookies_not_supported
signalka
Nature
Goodpaster, B. H. et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J. Gerontol. A. Biol. Sci. Med. Sci. 61, 1059-1064. https://doi.org/10.1093/gerona/61.10.1059 (2006).Article
PubMed
Aqoonyahan Google
Janssen, I.,...
PubMed
Aqoonyahan Google
Janssen, I.,...
256466
signalka
https://www.foxnews.com/health/cancer-trends-revealed-including-common-types-disease-and-biggest-risk-factors
signalka
FOXNews
Dr. Marc Siegel wuxuu ka falceliyaa waxa ka dambeeya sii kordhaya kiisaska kansarka ee dhalinyarada wuxuuna ku taliyay inay cunaan cunto caafimaad leh, yareeyaan isticmaalka khamriga, oo ay qaataan tallaalka HPV Ku dhawaad 40% dadka Mareykanka ah ayaa heli doona ogaanshaha kansarka mar ka mid ah noloshooda. - laakiin noocyada qaarkood ayaa aad u badan...
256467
signalka
https://twistedsifter.com/2024/04/could-alzheimers-spread-through-blood-transfusions-new-research-suggests-a-link/
signalka
Qalloocsanaan
Alzheimer's wuxuu leeyahay mid ka mid ah lacagaha cilmi-baarista ugu weyn ee cudur kasta oo jira, iyo sabab wanaagsan. Waxay ku dhacdaa dad badan, oo ma aha oo kaliya dadka dhibaataysan, laakiin kuwa jecel iyaga. Hadda, saynisyahannadu waxay helayaan caddayn ah in lagu faafi karo dhiig ku shubid fudud. Cilmi-baadhayaashu waxay shakiyeen muddo dheer in ka badan arrimaha hidde-sidaha ay ciyaaraan.
256469
signalka
https://www.medpagetoday.com/podcasts/healthwatch/109958
signalka
Medpage maanta
TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center in El Paso, look at the top medical stories of the week.
This week's...
This week's...
256491
signalka
https://www.pharmaceutical-technology.com/analyst-comment/astrazeneca-fasenra-copd-approval/
signalka
Farmasiga-farmasiga
AstraZeneca has recently announced that Fasenra has been approved for severe asthma, specifically for the eosinophilic phenotype, in children aged 6-11 years in more than 80 countries, including the US, EU, and Japan.
Fasenra is a monoclonal antibody that inhibits the alpha subunit of the...
Fasenra is a monoclonal antibody that inhibits the alpha subunit of the...
WAQTIGA MUSTAQBALKA
256490
signalka
https://www.beingpatient.com/what-are-biologics-for-alzheimers/
signalka
Bukaan-jiid
Haddii aad u aragto maqaalladayada iyo waraysiyadayada inay waxtar leeyihiin, fadlan ka fiirso inaad noqoto xubin taageeraya beeshayada. Annagoo ka niyad jabnay la'aanta isha tifaftirka madax-bannaan ee macluumaadka caafimaadka maskaxda iyo cudurka Alzheimers, waxaan go'aansannay inaan abuurno Bukaanka. Waxaan nahay koox saxafiyiin ah oo u heellan inay soo tebiyaan cilmi-baaristii ugu dambeysay ee Alzheimer' taasoo kuu keenaysa inaad la kulanto khubarada iyo kor u qaadista aragtida bukaan-socodka ee waxa ay la mid tahay in lala noolaado waallida.
WAQTIGA MUSTAQBALKA
256489
signalka
https://time.com/6972086/ozempic-anti-inflammatory-drug/
signalka
Time
Nearly a decade ago, a thin, soft-spoken twenty-something woman named Megan walked into my office and presented me with a meticulous hand-written file containing her gastrointestinal history. The file included descriptions of her initial diagnosis of Crohn's disease as a teenager, the multiple...
WAQTIGA MUSTAQBALKA
256488
signalka
https://www.nature.com/articles/d41586-024-01215-0?code=49a116c5-eeb3-4ba2-8fd0-34d9c9e00371&error=cookies_not_supported
signalka
Nature
US drug regulators dropped a bombshell in November 2023 when they announced an investigation into one of the most celebrated cancer treatments to emerge in decades. The US Food and Drug Administration (FDA) said it was looking at whether a strategy that involves engineering a person's immune cells to kill cancer was leading to new malignancies in people who had been treated with it.
WAQTIGA MUSTAQBALKA
256487
signalka
https://www.finsmes.com/2024/04/surf-bio-receives-1-6m-non-dilutive-grant-from-bill-melinda-gates-foundation.html
signalka
Finsmes
Surf Bio Receives $1.6M Non-Dilutive Grant From Bill & Melinda Gates Foundation
Surf Bio, a Palo Alto, CA-based biopharmaceutical company commercializing a novel drug stabilization platform, has received a $1.6M grant from the Bill & Melinda Gates Foundation.
Shirkaddu waxay ku talo jirtaa...
Surf Bio, a Palo Alto, CA-based biopharmaceutical company commercializing a novel drug stabilization platform, has received a $1.6M grant from the Bill & Melinda Gates Foundation.
Shirkaddu waxay ku talo jirtaa...
WAQTIGA MUSTAQBALKA
256486
signalka
https://www.finsmes.com/2024/04/enlaza-therapeutics-raises-100m-in-series-a-financing.html
signalka
Finsmes
Enlaza Therapeutics, a La Jolla, CA-based covalent biologic platform company, raised $100M in Series A funding.
The round was led by Life Sciences group of J.P. Morgan Asset Management's Private Capital division, with participation from existing investors Frazier Life Sciences, Avalon Ventures,...
The round was led by Life Sciences group of J.P. Morgan Asset Management's Private Capital division, with participation from existing investors Frazier Life Sciences, Avalon Ventures,...
WAQTIGA MUSTAQBALKA
256485
signalka
https://www.statnews.com/2024/04/30/economics-holding-back-promise-antibody-therapies-infectious-diseases/
signalka
Wararka
Next-generation broadly neutralizing antibodies (bnAbs) have the potential to transform the fight against global health threats like HIV, malaria, and Ebola. The commercialization of these innovative antibody therapies could save millions of lives annually. But turning promise into reality...
256468
signalka
https://www.cnbc.com/2024/05/05/within-a-few-years-generative-ai-will-design-new-drugs-on-its-own.html
signalka
Cnbc
The advances related to AI are taking place within a field of biology that has been increasingly digitized at what Powell describes as "unprecedented scales and resolutions." It's a medical revolution that includes spatial genomics scanning millions of cells within tissue, in 3-and AI model-building that specifically benefits from a catalog of chemicals already in a digital form which allows generative AI transformer models to now go to work on them.
256484
signalka
https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-nasdaqnrxp-announces-promising-findings-in-phase-2b3-clinical-trial-of-nrx-101-vs-lurasidone-for-treatment-of-suicidal-bipolar-depression-302131482.html
signalka
Prnewswire
NRX-101 is first oral antidepressant to show 33% advantage in sustained remission in suicidality (not statistically significant at this sample size) and 75% advantage in relief from Akathisia relative to lurasidone - never previously shown with an oral antidepressant. Suicidality signal met the...
256483
signalka
https://www.fda.gov/news-events/press-announcements/fda-roundup-april-30-2024
signalka
FDA
Si Degdeg ah u Siiso:
April 30, 2024
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:
Today, the FDA published the FDA Voices: "A Milestone in Facilitating the Development of Safe and Effective Biosimilars,"...
April 30, 2024
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:
Today, the FDA published the FDA Voices: "A Milestone in Facilitating the Development of Safe and Effective Biosimilars,"...
256482
signalka
https://www.cnbc.com/2024/05/01/healthy-returns-humira-sales-are-falling-but-abbvie-has-successors.html
signalka
Cnbc
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Sales of 's Humira are plummeting as the once-top-selling drug fights competition from cheaper biosimilars in the U.and abroad. . That was clear after AbbVie on Friday reported first-quarter revenue and adjusted profit that topped Wall Street's expectations, partly driven by strength in the drugmaker's immunology business.
256481
signalka
https://www.csrwire.com/press_releases/800871-jazz-pharmaceuticals-focuses-taking-actions-positively-impact-planet-earth
signalka
Csrwire
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases - often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology.
256471
signalka
https://www.forbes.com/sites/joshuacohen/2024/05/03/medicare-says-it-expects-to-spend-35-billion-in-2025-on-alzheimers-drug-leqembi-but-this-is-unlikely/
signalka
Forbes
ABINGTON, PA - NOV 7: Nurse Christine Besso, center, helps Robert Williford, 66, left, during his ... [+] first session of receive the newly FDA approved Alzheimer's treatment Leqembi while Williford's wife Cynthia Byron-Williford, 59, right, watches at Abington Neurological Associates in...
256473
signalka
https://www.jmir.org/2024/1/e48572/
signalka
Mining Real-World Big Data to Characterize Adverse Drug Reaction Quantitatively: Mixed Methods Study
Jmir
Introduction In recent years, the issue of drug toxicity has emerged as a serious concern in the fields of clinical medicine, pharmacology, and sociology. As a result, drug regulatory agencies worldwide are making continuous efforts to monitor marketed drugs and assess their potential risks in...
256472
signalka
https://www.finsmes.com/2024/05/latus-raises-54m-in-series-a-financing.html
signalka
Finsmes
Latus Bio, a Philadelphia, PA-based biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), raised $54M in Series A funding.
The round was led by 8VC and DCVC Bio.
To date, Samsung Life Science Fund (created by Samsung C&T, Samsung...
The round was led by 8VC and DCVC Bio.
To date, Samsung Life Science Fund (created by Samsung C&T, Samsung...
256479
signalka
https://www.healio.com/news/dermatology/20240501/eli-lillys-firstquarter-financial-results-highlight-resubmission-of-bla-for-lebrikizumab
signalka
Healio
Waxaa laga yaabaa 01, 2024
1 min akhris
Eli Lilly's first-quarter financial results highlight resubmission of BLA for lebrikizumab
Ku dar mawduuc ogeysiisyada iimaylka
Lagu daray iimaylka digniinaha
Waanu awoodi waynay inaanu ka baaraan degno codsigaaga Fadlan isku day mar kale hadhow Hadii aad...
1 min akhris
Eli Lilly's first-quarter financial results highlight resubmission of BLA for lebrikizumab
Ku dar mawduuc ogeysiisyada iimaylka
Lagu daray iimaylka digniinaha
Waanu awoodi waynay inaanu ka baaraan degno codsigaaga Fadlan isku day mar kale hadhow Hadii aad...
256470
signalka
https://www.startribune.com/thousands-believe-covid-vaccines-harmed-them-is-anyone-listening/600363571/
signalka
Startribune
Within minutes of getting the Johnson & Johnson COVID-19 vaccine, Michelle Zimmerman felt pain racing from her left arm up to her ear and down to her fingertips. Within days, she was unbearably sensitive to light and struggled to remember simple facts. She was 37, with a doctorate in neuroscience, and until then could ride her bicycle 20 miles, teach a dance class and give a lecture on artificial intelligence, all in the same day.
256480
signalka
https://www.pharmaceutical-technology.com/news/enlaza-series-a-funding/
signalka
Farmasiga-farmasiga
Enlaza Therapeutics has raised $100m in a Series A financing round headed by the Life Sciences group of JP Morgan Asset Management's private capital division.
The funding round also saw contributions from a mix of existing and new investors, including Frazier Life Sciences, Lightspeed Venture...
The funding round also saw contributions from a mix of existing and new investors, including Frazier Life Sciences, Lightspeed Venture...